Insider transactions

EDGAR

MEDIFAST, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
14 transactions, 148,862 shares
Sum of shares × price per share: 1,742,113.577
Open-market sales (code S)
2 transactions, 19,089 shares
Sum of shares × price per share: 226,288.766

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–38 of 38

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-04 Filed 2026-11-06Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)66113.0255
8,609.8555

Derived: shares × price per share. Exact value 8609.8555.

21,089Indirect (I) NotesNo
F1, F2, F3
  • F1 Ownership of Steamboat Capital Partners II, LP (II).
  • F2 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from II. Parsa Kiai (Kiai) is the Managing Member of GP. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F3 This is an average price. Actual prices paid for the shares purchased on 11/04/26 and reported on this line range from $12.87 to $13.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-116801 Read from the filing’s XML Dispute this row
2026-10-28 Filed 2026-10-30Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,39912.2417
66,092.9383

Derived: shares × price per share. Exact value 66092.9383.

712,891Indirect (I) NotesNo
F1, F3, F4
  • F1 Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 10/28/26 and reported on this line range from $12.205 to $12.25. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-114242 Read from the filing’s XML Dispute this row
2026-10-28 Filed 2026-10-30Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15812.2417
1,934.1886

Derived: shares × price per share. Exact value 1934.1886.

20,428Indirect (I) NotesNo
F2, F3, F4
  • F2 Ownership of Steamboat Capital Partners II, LP (II).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 10/28/26 and reported on this line range from $12.205 to $12.25. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-114242 Read from the filing’s XML Dispute this row
2026-09-29 Filed 2026-09-30Chard Daniel R Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,54411.73
111,951.12

Derived: shares × price per share. Exact value 111951.12.

130,609.352Indirect (I) The Dan and Allyson Family Irrevocable TrustYes
F3, F2
  • F3 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.670 to $11.810, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
Open filing 0001628280-26-064063 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Chard Daniel R Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,54511.9788
114,337.646

Derived: shares × price per share. Exact value 114337.6460.

140,153.352Indirect (I) The Dan and Allyson Family Irrevocable TrustYes
F1, F2
  • F1 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.900 to $12.125, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
Open filing 0001628280-26-064063 Read from the filing’s XML Dispute this row
2026-08-26 Filed 2026-08-28Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)41,97512.2632
514,747.82

Derived: shares × price per share. Exact value 514747.8200.

707,492Indirect (I) NotesNo
F1, F3, F4
  • F1 Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 8/26/26 and reported on this line range from $12.12 to $12.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-094862 Read from the filing’s XML Dispute this row
2026-08-26 Filed 2026-08-28Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,17512.2632
14,409.26

Derived: shares × price per share. Exact value 14409.2600.

20,270Indirect (I) NotesNo
F2, F3, F4
  • F2 Ownership of Steamboat Capital Partners II, LP (II).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 8/26/26 and reported on this line range from $12.12 to $12.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-094862 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-26Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)4,21111.9996
50,530.3156

Derived: shares × price per share. Exact value 50530.3156.

665,517Indirect (I) NotesNo
F1, F3, F4
  • F1 Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 8/24/26 and reported on this line range from $11.99 to $12. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-093824 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-26Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)11811.9996
1,415.9528

Derived: shares × price per share. Exact value 1415.9528.

19,095Indirect (I) NotesNo
F2, F3, F4
  • F2 Ownership of Steamboat Capital Partners II, LP (II).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 8/24/26 and reported on this line range from $11.99 to $12. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-093824 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-21Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)41,97511.6037
487,065.3075

Derived: shares × price per share. Exact value 487065.3075.

661,306Indirect (I) NotesNo
F1, F3, F5
  • F1 Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F5 This is an average price. Actual prices paid for the shares purchased on 8/20/26 and reported on this line range from $11.46 to $11.77. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-092479 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-21Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,17511.6037
13,634.3475

Derived: shares × price per share. Exact value 13634.3475.

18,977Indirect (I) NotesNo
F2, F3, F5
  • F2 Ownership of Steamboat Capital Partners II, LP (II).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F5 This is an average price. Actual prices paid for the shares purchased on 8/20/26 and reported on this line range from $11.46 to $11.77. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-092479 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)28,53811.6576
332,684.5888

Derived: shares × price per share. Exact value 332684.5888.

619,331Indirect (I) NotesNo
F1, F3, F4
  • F1 Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 8/19/26 and reported on this line range from $11.56 to $11.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-092479 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Kiai Parsa Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)79911.6576
9,314.4224

Derived: shares × price per share. Exact value 9314.4224.

17,802Indirect (I) NotesNo
F2, F3, F4
  • F2 Ownership of Steamboat Capital Partners II, LP (II).
  • F3 Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai (Kiai) is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
  • F4 This is an average price. Actual prices paid for the shares purchased on 8/19/26 and reported on this line range from $11.56 to $11.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001213900-26-092479 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28SCHLACKMAN SCOTT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11,6800—42,228.707Direct (D) No
F1
  • F1 These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the Plan), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Open filing 0001628280-26-038976 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Kiai Parsa Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11,6800—11,680Direct (D) No
F1
  • F1 These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the Plan), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Open filing 0001628280-26-038981 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Kiai Parsa Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,6370—19,317Direct (D) No
F2
  • F2 The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
Open filing 0001628280-26-038981 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Xian Ming Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (cash settled) — underlying Common Stock (11,680)
Acquired (A)11,6800—43,822.918Direct (D) No
F1
  • F1 Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on May 26, 2027. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.
Open filing 0001628280-26-038972 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Geary Elizabeth A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11,6800—31,225Direct (D) No
F1
  • F1 These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the Plan), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Open filing 0001628280-26-038974 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Thomas Andrea B Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11,6800—35,697.123Direct (D) No
F1
  • F1 These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the Plan), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Open filing 0001628280-26-038978 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Rose Jeffrey Matthew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11,6800—11,680Direct (D) No
F1
  • F1 These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the Plan), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Open filing 0001628280-26-038983 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Rose Jeffrey Matthew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,7390—18,419Direct (D) No
F2
  • F2 The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
Open filing 0001628280-26-038983 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-12SCHLACKMAN SCOTT Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,50012.53
31,325

Derived: shares × price per share. Exact value 31325.00.

30,548.707Direct (D) No— Open filing 0001628280-26-034271 Read from the filing’s XML Dispute this row
2026-05-08 Filed 2026-05-12SCHLACKMAN SCOTT Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,50012.65
31,625

Derived: shares × price per share. Exact value 31625.00.

28,048.707Direct (D) No— Open filing 0001628280-26-034271 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27Maloney James P. Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,2249.59
30,918.16

Derived: shares × price per share. Exact value 30918.16.

37,675Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021796 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27Maloney James P. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)34,3440—72,019Direct (D) No
F2
  • F2 Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Open filing 0001628280-26-021796 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27Maloney James P. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,0140—73,033Direct (D) No
F3
  • F3 Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock.
Open filing 0001628280-26-021796 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27MacKenzie Jonathan Barrett Officer: VP, Finance CAO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)8629.59
8,266.58

Derived: shares × price per share. Exact value 8266.58.

10,008Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021797 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27MacKenzie Jonathan Barrett Officer: VP, Finance CAO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10,8300—20,838Direct (D) No
F2
  • F2 Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Open filing 0001628280-26-021797 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27Chard Daniel R Director · Officer: Chairman CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)20,0959.59
192,711.05

Derived: shares × price per share. Exact value 192711.05.

146,438Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021795 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27Chard Daniel R Director · Officer: Chairman CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,9680—183,406Direct (D) No
F5
  • F5 Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Open filing 0001628280-26-021795 Read from the filing’s XML Dispute this row
2026-03-25 Filed 2026-03-27Chard Daniel R Director · Officer: Chairman CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,8270—188,233Direct (D) No
F6
  • F6 Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock.
Open filing 0001628280-26-021795 Read from the filing’s XML Dispute this row
2026-03-20 Filed 2026-03-27Chard Daniel R Director · Officer: Chairman CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)17,67810.11
178,724.58

Derived: shares × price per share. Exact value 178724.58.

17,678Indirect (I) Dan and Allyson as Joint TenantsNo
F2, F3
  • F2 The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.04 to $10.18, inclusive.
  • F3 These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse.
Open filing 0001628280-26-021795 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-27Maloney James P. Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)48210.05
4,844.1

Derived: shares × price per share. Exact value 4844.10.

40,899Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021796 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-27MacKenzie Jonathan Barrett Officer: VP, Finance CAO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)7010.05
703.5

Derived: shares × price per share. Exact value 703.50.

10,870Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021797 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-27Chard Daniel R Director · Officer: Chairman CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,63810.05
26,511.9

Derived: shares × price per share. Exact value 26511.90.

166,533Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021795 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-27Maloney James P. Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9189.62
8,831.16

Derived: shares × price per share. Exact value 8831.16.

41,381Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021796 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-27MacKenzie Jonathan Barrett Officer: VP, Finance CAO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1989.62
1,904.76

Derived: shares × price per share. Exact value 1904.76.

10,940Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021797 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-27Chard Daniel R Director · Officer: Chairman CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)7,0759.62
68,061.5

Derived: shares × price per share. Exact value 68061.50.

169,171Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
Open filing 0001628280-26-021795 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 111

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager858,513 SH9,890,070 dollarsHigher by 79,903 Prior quarter: 778,610Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Steamboat Capital Partners, LLC 845,709 SH9,742,568 dollarsHigher by 139,010 Prior quarter: 706,699Open filing 0001635663-26-000008 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager513,198 SH5,912,040 dollarsHigher by 143,695 Prior quarter: 369,503Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 492,692 SH5,675,812 dollarsHigher by 11,311 Prior quarter: 481,381Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 446,614 SH5,144,993 dollarsUnchanged Prior quarter: 446,614Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager439,221 SH5,059,826 dollarsHigher by 120,310 Prior quarter: 318,911Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager373,439 SH4,302,066 dollarsHigher by 10,045 Prior quarter: 363,394Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager352,704 SH4,063,150 dollarsHigher by 111,055 Prior quarter: 241,649Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager244,294 SH2,814,274 dollarsLower by 48,214 Prior quarter: 292,508Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Peapod Lane Capital LLC 207,502 SH2,390,423 dollarsLower by 15,074 Prior quarter: 222,576Open filing 0001941040-26-000768 Filed 2026-10-22 Dispute this row
Lido Advisors, LLC 201,248 SH2,318,381 dollarsLower by 19,089 Prior quarter: 220,337Open filing 0001172661-26-004854 Filed 2026-11-04 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager199,100 SH2,293,632 dollarsLower by 343,600 Prior quarter: 542,700Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
COMMONS CAPITAL, LLC 184,432 SH2,124,657 dollarsHigher by 34,516 Prior quarter: 149,916Open filing 0001951757-26-001978 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 178,026 SH2,050,860 dollarsLower by 218,970 Prior quarter: 396,996Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
BRIDGEWAY CAPITAL MANAGEMENT, LLC 164,220 SH1,891,814 dollarsHigher by 47,142 Prior quarter: 117,078Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager158,500 SH1,825,920 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
GSA CAPITAL PARTNERS LLP 150,747 SH1,737 dollarsHigher by 112,304 Prior quarter: 38,443Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
IMC-Chicago, LLC Option: Call 150,500 SH1,733,760 dollarsLower by 22,200 Prior quarter: 172,700Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
Trexquant Investment LP Partly reported under another manager145,336 SH1,674,271 dollarsLower by 67,348 Prior quarter: 212,684Open filing 0001633445-26-000008 Filed 2026-11-16 Dispute this row
Quinn Opportunity Partners LLC Partly reported under another manager127,112 SH1,464,330 dollarsUnchanged Prior quarter: 127,112Open filing 0001633275-26-000013 Filed 2026-11-10 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager124,997 SH1,439,965 dollarsHigher by 51,119 Prior quarter: 73,878Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager122,602 SH1,412,375 dollarsLower by 120,483 Prior quarter: 243,085Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager117,440 SH1,353,732 dollarsLower by 3,631 Prior quarter: 121,071Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
TUDOR INVESTMENT CORP ET AL 108,377 SH1,248,503 dollarsHigher by 32,346 Prior quarter: 76,031Open filing 0000902664-26-004567 Filed 2026-11-16 Dispute this row
GROUP ONE TRADING LLC Option: Call 89,900 SH1,035,648 dollarsLower by 198,700 Prior quarter: 288,600Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager87,575 SH1,008,864 dollarsHigher by 31,225 Prior quarter: 56,350Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Option: Put Partly reported under another manager83,600 SH963,072 dollarsHigher by 18,000 Prior quarter: 65,600Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
RBF Capital, LLC 83,244 SH958,971 dollarsLower by 25,756 Prior quarter: 109,000Open filing 0001062993-26-005971 Filed 2026-11-13 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager82,786 SH953,695 dollarsHigher by 13,181 Prior quarter: 69,605Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
Divisadero Street Capital Management, LP 79,839 SH919,745 dollarsUnchanged Prior quarter: 79,839Open filing 0001901865-26-000005 Filed 2026-11-16 Dispute this row
Virtus Family Office LLC 79,060 SH910,771 dollarsUnchanged Prior quarter: 79,060Open filing 0001214659-26-013482 Filed 2026-10-30 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager70,615 SH819,840 dollarsLower by 21,897 Prior quarter: 92,512Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Empowered Funds, LLC Partly reported under another manager66,054 SH760,942 dollarsLower by 51 Prior quarter: 66,105Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 63,337 SH729,642 dollarsUnchanged Prior quarter: 63,337Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager55,200 SH635,904 dollarsLower by 178,200 Prior quarter: 233,400Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager54,855 SH631,930 dollarsHigher by 2,536 Prior quarter: 52,319Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Quantinno Capital Management LP 51,588 SH594,294 dollarsLower by 31,409 Prior quarter: 82,997Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager48,173 SH551 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
PRUDENTIAL FINANCIAL INC Partly reported under another manager46,818 SH539,343 dollarsNot in the prior quarter’s filings read Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row
SIMPLEX TRADING, LLC Option: Call 46,200 SH532,224 dollarsLower by 59,200 Prior quarter: 105,400Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
IMC-Chicago, LLC Option: Put 45,000 SH518,400 dollarsLower by 31,300 Prior quarter: 76,300Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
Corient Private Wealth LP 44,375 SH511,199 dollarsNot in the prior quarter’s filings read Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row
Engineers Gate Manager LP 41,897 SH482,653 dollarsLower by 7,932 Prior quarter: 49,829Open filing 0001620220-26-000010 Filed 2026-11-16 Dispute this row
Susquehanna Portfolio Strategies, LLC 41,777 SH481,271 dollarsUnchanged Prior quarter: 41,777Open filing 0001996449-26-000009 Filed 2026-11-16 Dispute this row
SummerHaven Investment Management, LLC 41,157 SH787,745 dollarsLower by 6,678 Prior quarter: 47,835Open filing 0001420506-26-002325 Filed 2026-10-16 Dispute this row
GREAT LAKES ADVISORS, LLC 39,619 SH456,411 dollarsLower by 11,992 Prior quarter: 51,611Open filing 0001078013-26-000008 Filed 2026-11-06 Dispute this row
Point72 Asset Management, L.P. 39,097 SH450,397 dollarsHigher by 18,098 Prior quarter: 20,999Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager36,417 SH419,524 dollarsLower by 200,017 Prior quarter: 236,434Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
Walleye Capital LLC Option: Call 35,400 SH407,808 dollarsHigher by 18,200 Prior quarter: 17,200Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager34,599 SH398,580 dollarsLower by 57,746 Prior quarter: 92,345Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 396,996 SH
  • JANE STREET GROUP, LLC 164,881 SH
  • Walleye Trading LLC 108,000 SH
  • BANK OF AMERICA CORP /DE/ 87,118 SH
  • Atom Investors LP 62,119 SH
  • Jump Financial, LLC 40,500 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 39,800 SH
  • VICTORY CAPITAL MANAGEMENT INC 35,655 SH
  • Jain Global LLC 35,223 SH
  • PEAK6 LLC 31,400 SH
  • XTX Topco Ltd 30,654 SH
  • Marquette Asset Management, LLC 30,038 SH
  • VANGUARD PORTFOLIO MANAGEMENT LLC 29,108 SH
  • Chico Wealth RIA 21,000 SH
  • Squarepoint Ops LLC 20,140 SH
  • State of Wyoming 18,594 SH
  • MERCER GLOBAL ADVISORS INC /ADV 16,782 SH
  • Invesco Ltd. 13,315 SH
  • IEQ CAPITAL, LLC 10,740 SH
  • WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 10,683 SH
  • Verdad Advisers, LP 10,234 SH
  • Walleye Trading LLC 3,400 SH
  • Walleye Capital LLC 1,452 SH
  • Integrated Wealth Concepts LLC 1,064 SH
  • Pinnacle Wealth Planning Services, Inc. 631 SH
  • GILL CAPITAL PARTNERS, LLC 108 SH
  • True Wealth Design, LLC 90 SH
  • Essential Partners LLC 81 SH
  • ROTHSCHILD INVESTMENT LLC 62 SH
  • Paladin Partners, LLC 30 SH
  • Fortitude Family Office, LLC 18 SH
  • Covestor Ltd 15 SH
  • Clearstead Advisors, LLC 2 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–2 of 2

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Donna Shalala (FL27)2019-06-24Sale$1,001 - $15,0002020-04-27
Hon. Donna Shalala (FL27)2019-04-30Purchase$1,001 - $15,0002020-04-27

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Susquehanna Portfolio Strategies, LLC Common Stock, $0.001 par value per share2.3252,23309/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001446580-26-000113 Dispute this row
Susquehanna Securities, LLC Common Stock, $0.001 par value per share2.3252,23309/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001446580-26-000113 Dispute this row
Steamboat Capital Partners, LLC Common Stock, $0.001 par value7.1790,693.0008/20/2026 Filed 2026-08-21SCHEDULE 13D/AAmendment 1Open filing 0001213900-26-092590 Dispute this row
Parsa Kiai Common Stock, $0.001 par value7.1790,693.0008/20/2026 Filed 2026-08-21SCHEDULE 13D/AAmendment 1Open filing 0001213900-26-092590 Dispute this row
Susquehanna Portfolio Strategies, LLC Common Stock, $0.001 par value per share5.3587,21406/30/2026 Filed 2026-08-14SCHEDULE 13GOpen filing 0001446580-26-000098 Dispute this row
Susquehanna Securities, LLC Common Stock, $0.001 par value per share5.3587,21406/30/2026 Filed 2026-08-14SCHEDULE 13GOpen filing 0001446580-26-000098 Dispute this row
Citadel Securities GP LLC Common Stock, par value $0.001 per share (the "Shares")2.1236,447.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
Citadel Securities LLC Common Stock, par value $0.001 per share (the "Shares")2.1233,401.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
Citadel Securities Group LP Common Stock, par value $0.001 per share (the "Shares")2.1236,447.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
Citadel Advisors LLC Common Stock, par value $0.001 per share (the "Shares")0.553,304.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
Citadel Advisors Holdings LP Common Stock, par value $0.001 per share (the "Shares")0.553,304.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
Citadel GP LLC Common Stock, par value $0.001 per share (the "Shares")0.553,304.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
Kenneth Griffin Common Stock, par value $0.001 per share (the "Shares")2.6289,751.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097161 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Common Stock3.6396,99606/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 3Open filing 0000884546-26-000396 Dispute this row
BlackRock, Inc. Common Stock2.9327,40406/30/2026 Filed 2026-07-29SCHEDULE 13G/AAmendment 19Open filing 0002012383-26-002827 Dispute this row
Citadel Securities GP LLC Common Stock, par value $0.001 per share (the "Shares")6.5715,910.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
Citadel Securities LLC Common Stock, par value $0.001 per share (the "Shares")6.5712,864.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
Citadel Securities Group LP Common Stock, par value $0.001 per share (the "Shares")6.5715,910.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
Citadel Advisors LLC Common Stock, par value $0.001 per share (the "Shares")0.00.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
Citadel Advisors Holdings LP Common Stock, par value $0.001 per share (the "Shares")0.00.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
Citadel GP LLC Common Stock, par value $0.001 per share (the "Shares")0.00.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
Kenneth Griffin Common Stock, par value $0.001 per share (the "Shares")6.5715,910.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001104659-26-062726 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Common Stock5.74003/31/2026 Filed 2026-05-14SCHEDULE 13G/AAmendment 2Open filing 0000884546-26-000217 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 11Open filing 0000102909-26-001762 Dispute this row
Steamboat Capital Partners, LLC Common Stock, $0.001 par value6.0657,590.0003/13/2026 Filed 2026-03-20SCHEDULE 13DOpen filing 0001213900-26-032212 Dispute this row
Parsa Kiai Common Stock, $0.001 par value6.0657,590.0003/13/2026 Filed 2026-03-20SCHEDULE 13DOpen filing 0001213900-26-032212 Dispute this row
Renaissance Technologies LLC Common Stock, $0.001 par value per share6.96773,71001/02/2026 Filed 2026-05-14SCHEDULE 13G/AAmendment 11Open filing 0001037389-26-000039 Dispute this row
Renaissance Technologies Holdings Corporation Common Stock, $0.001 par value per share6.96773,71001/02/2026 Filed 2026-05-14SCHEDULE 13G/AAmendment 11Open filing 0001037389-26-000039 Dispute this row
G1 Execution Services, LLC Common Stock, $0.001 par value per share1.4148,94412/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0001446580-26-000039 Dispute this row
Susquehanna Fundamental Investments, LLC Common Stock, $0.001 par value per share1.4148,94412/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0001446580-26-000039 Dispute this row
Susquehanna Securities, LLC Common Stock, $0.001 par value per share1.4148,94412/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0001446580-26-000039 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Common Stock7.06776,82912/31/2025 Filed 2026-02-12SCHEDULE 13G/AAmendment 1Open filing 0000884546-26-000009 Dispute this row
G1 Execution Services, LLC Common Stock, $0.001 par value per share6.0654,94509/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0001446580-25-000121 Dispute this row
Susquehanna Fundamental Investments, LLC Common Stock, $0.001 par value per share6.0654,94509/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0001446580-25-000121 Dispute this row
Susquehanna Securities, LLC Common Stock, $0.001 par value per share6.0654,94509/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0001446580-25-000121 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Common Stock5.41595,21109/30/2025 Filed 2025-11-13SCHEDULE 13GOpen filing 0000884546-25-000006 Dispute this row
G1 Execution Services, LLC Common Stock, $0.001 par value per share7.2785,60606/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001446580-25-000071 Dispute this row
Susquehanna Fundamental Investments, LLC Common Stock, $0.001 par value per share7.2785,60606/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001446580-25-000071 Dispute this row
Susquehanna Securities, LLC Common Stock, $0.001 par value per share7.2785,60606/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001446580-25-000071 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,556,900 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020183,193
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to MEDIFAST, INC.